KLOW

80mg blend: 50mg GHK-Cu + 10mg KPV + 10mg TB-500 + 10mg BPC-157

Enlarge

Price · per pack

£500.00

Available to order

£700.00 Save £200.00 (29%)

£50.00 per vial · 10 vials per case

Free delivery £50+ Royal Mail Tracked 24

Approx. 2-week lead time. Dispatch follows availability.

Batch documentation

COA not yet available. Ask about documentation →

Explore research & studies

Product overview & specifications

KLOW in 10-vial case. Check the product record for the stated strength, storage information and batch-document availability.

Strength: 80mg × 10 vials
Presentation: 10-vial case
Batch documentation: availability shown on this listing

Strength80mg × 10 vials

Presentation10-vial case

Purity99%+

Storage2-8 C

Part number: KLOW80-10PK
Storage: Store refrigerated at 2-8 C, protected from light.
COA: Added to your account when available
Delivery: Royal Mail Tracked 24 is £4.95, or free on merchandise subtotals of £50+; Approx. 2-week lead time
Tracking: Emailed once dispatched and shown in your profile
Contents: Powder vial
Status: Research use only

For laboratory research only

For laboratory research use only. Not for human or veterinary use. No use instructions or medical guidance is provided. Understand COA documentation.

Research information

KLOW research profile

What is being studied?

KLOW is a multi-component research blend rather than a single molecular entity. It combines a copper-binding tripeptide complex, the Lys-Pro-Val tripeptide, a thymosin-beta-derived research component and BPC-157 in one documented presentation.

The blend format is suited to controlled comparison of the combined preparation against its individual components. Published component studies cover copper-dependent matrix signalling, KPV transport and inflammatory-pathway assays, thymosin-beta/actin interactions and BPC-157 cell-migration models; they do not demonstrate that the mixture has a single established mechanism.

Research areas

Blend-versus-component comparison in controlled cell-based assays
Multi-pathway extracellular-matrix and cell-migration research
Analytical assessment of component identity and blend consistency

Selected studies

Cell and animal study · 2008
PepT1-mediated KPV uptake and signalling assays ↗
Investigated KPV transport and inflammatory signalling in cell assays and mouse models; it did not test KLOW.
Cell and tissue study · 2011
BPC-157 and fibroblast migration through FAK-paxillin ↗
Investigated BPC-157 in rat tendon explants and cultured fibroblasts; it did not test a combined blend.
Related peptide study · 2003
The actin-binding site on thymosin beta-4 ↗
Studied thymosin beta-4 and its actin-binding fragments in cell and tissue models. This does not verify the supplied TB-500 material or blend.

How to read this research

These papers study defined compounds in specific experimental systems or clinical trials. They do not test or certify this product, its batch or its prepared presentation. Component and related-peptide studies do not establish the effects of a finished blend. Findings are research context, not evidence of safety or suitability for personal use. For laboratory research only; no treatment, dosing or use advice is provided.

Technical product record

KLOW research record

Molecular identity and stated sequence or composition, alongside the batch, storage, dispatch and document record for this 10-vial case.

Molecular identity

Four-component peptide research blend

Sequence / composition

50mg GHK-Cu + 10mg KPV + 10mg TB-500 + 10mg BPC-157

Product record

The listing identifies the presentation, specification, storage record, dispatch status, and batch-document availability for the relevant product or batch.

Use restriction

For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.